Gestational trophoblastic neoplasia in American Indians

被引:0
作者
Smith, HO
Qualls, CR
Hilgers, RD
Verschraegen, CF
Rayburn, WF
Cole, LW
Padilla, LA
Key, CR
机构
[1] Univ New Mexico, Dept Obstet & Gynecol, Hlth Sci Ctr, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA
[3] Univ New Mexico, New Mexico Tumor Reg, Hlth Sci Ctr, Albuquerque, NM 87131 USA
[4] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA
[5] Univ Louisville, Canc Res Treatment Ctr, Div Hematol Oncol, Invest Drug Program, Louisville, KY 40292 USA
关键词
trophoblastic neoplasms; Indians; North American; choriocarcinoma;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To analyze gestational trophoblastic neoplasia (GTN) trends among American Indians (AI) using population-based data. STUDY DESIGN: GTN incidence, by race and age, was calculated using data collected by the New Mexico Tumor Registry over 29 years (1973-2001). Live birth, pregnancy and women at risk were tabulated using data derived from the state's vital record annual reports and from the registry. Statistical methods included trends analysis and Poisson regression. There is no national registry in the United States for all GTN. Therefore, the Surveillance, Epidemiology and End Results (SEER) database was used to identify choriocarcinoma cases in American Indians between 1973 and 1999. RESULTS: Within New Mexico, 1,082 cases of GTN were identified among 752,374 live births and 904,831 pregnancies, with ratios of 1:695 and 1:836, respectively, affecting 234 AI, 355 non-Hispanic whites (NHW), 463 Hispanic whites (HW) and 30 other nonwhites. Ratios per live births (pregnancy), respectively, were significantly higher in AI (AI 1:439 [1:487], NHW 1:739 [1:949], HW 1:783 [1:903]), as was age-adjusted incidence per 100,000 woman-years (AI 10.62, NHW 3.53, HW 5.15, all P<.0001). Using Poisson models with live birth and woman-year denominators, AI were found to be at increased risk for all GTN histologic subsets (complete, partial and invasive hydatidiform mole and choriocarcinoma). Of 524 total gestational choriocarcinoma cases identified within SEER, 8 (1.8%) affected American Indians; of them, 7 were from New Mexico. CONCLUSION: In New Mexico, AI continue to be at higher risk of GTN than are other groups. Given the rarity of choriocarcinoma within SEER, especially among AI, the New Mexico dataset provides the best available estimate of trends in U.S. AI GTN risk.
引用
收藏
页码:535 / 544
页数:10
相关论文
共 50 条
  • [31] GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study
    Verri, Debora
    Pasciuto, Tina
    Epstein, Elisabeth
    Fruscio, Robert
    Mascilini, Floriana
    Moro, Francesca
    Scambia, Giovanni
    Valentin, Lil
    Testa, Antonia Carla
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (07) : 1216 - 1220
  • [32] Treatment of High-Risk Gestational Trophoblastic Neoplasia
    Braga, Antonio
    Paiva, Gabriela
    Alevato, Raphael
    Elias, Kevin M.
    Horowitz, Neil S.
    Berkowitz, Ross S.
    Saldanha, Penelope
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (06) : 1245 - 1258
  • [33] Gestational trophoblastic neoplasia with retroperitoneal metastases: A fatal complication
    Nikolaos Thomakos
    Alexandros Rodolakis
    Panayiotis Belitsos
    Flora Zagouri
    Ioannis Chatzinikolaou
    Athanassios-Meletios Dimopoulos
    Christos A Papadimitriou
    Aris Antsaklis
    World Journal of Surgical Oncology, 8
  • [34] Recurrence and resistance risk factors in low-risk gestational trophoblastic neoplasia
    Branco-Silva, Mariza
    Maesta, Izildinha
    Horowitz, Neil
    Elias, Kevin
    Seckl, Michael
    Berkowitz, Ross
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [35] Clinicopathologic Analysis of Postchemotherapy Gestational Trophoblastic Neoplasia: An Entity Overlapping With Epithelioid Trophoblastic Tumor
    Lu, Bingjian
    Zhang, Xiaofei
    Liang, Yun
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2016, 35 (06) : 516 - 524
  • [36] Molecular profiling of gestational trophoblastic neoplasia: Identifying therapeutic targets
    Mcnally, Leah
    Wu, Sharon
    Hodges, Kurt
    Oberley, Matt
    Wallbillich, John J.
    Jones, Nathaniel L.
    Herzog, Thomas J.
    Thaker, Premal H.
    Secord, Angeles Alvarez
    Huang, Marilyn
    GYNECOLOGIC ONCOLOGY, 2024, 184 : 111 - 116
  • [37] Survival of Women with Gestational Trophoblastic Neoplasia and Liver Metastases Is It Improving?
    Ahamed, Eliyaz
    Short, Dee
    North, Bernard
    Savage, Philip M.
    Seckl, Michael J.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2012, 57 (5-6) : 262 - 269
  • [38] The optimal management of brain metastases from gestational trophoblastic neoplasia
    Tsai, Joseph
    Vellayappan, Balamurugan
    Venur, Vyshak
    McGranahan, Tresa
    Gray, Heidi
    Urban, Renata R.
    Tseng, Yolanda D.
    Palmer, Joshua
    Foote, Matthew
    Mayr, Nina A.
    Combs, Stephanie E.
    Sahgal, Arjun
    Chang, Eric L.
    Lo, Simon S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (03) : 307 - 315
  • [39] Gestational Trophoblastic Neoplasia: Diagnosis, Management, and Emerging Therapeutic Strategies
    Gupta, Sumedha
    Ahuja, Sana
    Kalwaniya, Dheer Singh
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2025, 23 (01)
  • [40] Reduction of Postmolar Gestational Trophoblastic Neoplasia by Early Diagnosis and Treatment
    Ben-Arie, Alon
    Deutsch, Hagit
    Volach, Vania
    Peer, Gil
    Husar, Monica
    Lavie, Ofer
    Gemer, Ofer
    JOURNAL OF REPRODUCTIVE MEDICINE, 2009, 54 (03) : 151 - 154